Adherence to Antihypertensive Medications in Iranian Patients

Table 3

Comparison of number of antihypertensives and comorbidities between low and moderate/high adherence groups among 280 Iranian hypertensive patients.

	Total; ()	Low adherers; ()	Moderate/high adherers; ()	Sig.
Antihypertensive therapy
Monotherapy	127 (45.3%)	68 (53.5%)	59 (46.5%)	0.234
Combination therapy	153 (54.6%)	71 (46.4%)	82 (53.6%)
Number of antihypertensive(s) classes taken
1	127 (45.3%)	68 (53.5%)	59 (46.5%)	0.079
2	95 (34%)	37 (38.9%)	58 (61.1%)
3–5	58 (20.7%)	34 (58.6%)	24 (41.4%)
Presence of comorbidity	160 (57.1%)	77 (48.1%)	83 (51.9%)	0.629
Mean (±SD) number of comorbidities, patients with at least one comorbidity	1.54 (±0.76)	1.53 (±0.75)	1.54 (±0.77)	0.984
Taking anti-hypertensive from pharmacy without doctor visit	212 (75.7%)	113 (53.3%)	99 (46.7%)	0.031